These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11884288)

  • 21. Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis.
    Gladue RP; Carroll LA; Milici AJ; Scampoli DN; Stukenbrok HA; Pettipher ER; Salter ED; Contillo L; Showell HJ
    J Exp Med; 1996 Apr; 183(4):1893-8. PubMed ID: 8666945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotriene binding, signaling, and analysis of HIV coreceptor function in mouse and human leukotriene B4 receptor-transfected cells.
    Martin V; Ronde P; Unett D; Wong A; Hoffman TL; Edinger AL; Doms RW; Funk CD
    J Biol Chem; 1999 Mar; 274(13):8597-603. PubMed ID: 10085095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
    Showell HJ; Conklyn MJ; Alpert R; Hingorani GP; Wright KF; Smith MA; Stam E; Salter ED; Scampoli DN; Meltzer S; Reiter LA; Koch K; Piscopio AD; Cortina SR; Lopez-Anaya A; Pettipher ER; Milici AJ; Griffiths RJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):946-54. PubMed ID: 9618393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
    Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
    Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE-/- mice.
    Ketelhuth DF; Hermansson A; Hlawaty H; Letourneur D; Yan ZQ; Bäck M
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):105-9. PubMed ID: 26051858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of leukotriene receptor BLT-2 reduces vascular oxidative stress and improves endothelial function in ApoE-/- mice.
    Hoyer FF; Albrecht L; Nickenig G; Müller C
    Mol Cell Biochem; 2012 Jan; 359(1-2):25-31. PubMed ID: 21755457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.
    Aiello RJ; Bourassa PA; Lindsey S; Weng W; Natoli E; Rollins BJ; Milos PM
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1518-25. PubMed ID: 10364084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.
    Li RC; Haribabu B; Mathis SP; Kim J; Gozal D
    Am J Respir Crit Care Med; 2011 Jul; 184(1):124-31. PubMed ID: 21493735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells.
    Jiang JX; Zhang SJ; Xiong YK; Jia YL; Sun YH; Lin XX; Shen HJ; Xie QM; Yan XF
    PLoS One; 2015; 10(6):e0128278. PubMed ID: 26035589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models.
    Sasaki F; Koga T; Ohba M; Saeki K; Okuno T; Ishikawa K; Nakama T; Nakao S; Yoshida S; Ishibashi T; Ahmadieh H; Kanavi MR; Hafezi-Moghadam A; Penninger JM; Sonoda KH; Yokomizo T
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localisation of mRNA for JE/MCP-1 and its receptor CCR2 in atherosclerotic lesions of the ApoE knockout mouse.
    Rayner K; Van Eersel S; Groot PH; Reape TJ
    J Vasc Res; 2000; 37(2):93-102. PubMed ID: 10754394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
    Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice.
    Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A
    Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
    Boring L; Gosling J; Cleary M; Charo IF
    Nature; 1998 Aug; 394(6696):894-7. PubMed ID: 9732872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression.
    van Royen N; Hoefer I; Böttinger M; Hua J; Grundmann S; Voskuil M; Bode C; Schaper W; Buschmann I; Piek JJ
    Circ Res; 2003 Feb; 92(2):218-25. PubMed ID: 12574150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration.
    Yamashita T; Kawashima S; Ozaki M; Namiki M; Inoue N; Hirata K; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):969-74. PubMed ID: 12067906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.